HBK Investments’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-23,917
Closed -$590K 1094
2016
Q2
$590K Sell
23,917
-28,361
-54% -$704K ﹤0.01% 690
2016
Q1
$1.16M Buy
52,278
+5,203
+11% +$138K 0.01% 559
2015
Q4
$1.65M Buy
47,075
+26,775
+132% +$839K 0.02% 453
2015
Q3
$578K Buy
+20,300
New +$682K 0.01% 718
2015
Q1
Sell
-54,000
Closed -$1.12M 1243
2014
Q4
$1.12M Buy
54,000
+4,600
+9% +$109K 0.01% 514
2014
Q3
$1.21M Buy
+49,400
New +$1.31M 0.02% 487

Other funds holding PMC

HBK Investments's PMC Position: Q3 2016 in Review

HBK Investments sold out of PharMerica Corporation (PMC) in Q3 2016, closing a stake of 23,917 shares — an estimated $590K sold.

HBK Investments first reported a position in PMC in Q3 2014 and held it in 6 quarters. The position peaked at $1.65M in Q4 2015. 172 funds tracked by Wall St. Rank hold PMC as of Q3 2016.

  • HBK Investments reported no remaining PharMerica Corporation position as of Q3 2016 after selling out during the quarter.
  • HBK Investments sold 23,917 PharMerica Corporation shares in Q3 2016, an estimated $590K.
  • HBK Investments first reported a position in PharMerica Corporation in Q3 2014 and held it in 6 quarters.
  • HBK Investments's PharMerica Corporation position peaked at $1.65M in Q4 2015.
  • 172 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2016.

Based on HBK Investments's 13F filing for Q3 2016, filed 14 Nov 2016.